The FY2025 (Dec) proxy of Anika Therapeutics names 17 peer companies for pay. Pay versus performance data of Anika Therapeutics for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Axogen | ||
| Travere Therapeutics | ||
| Mimedx Group | ||
| Artivion | ||
| Organogenesis Holdings | ||
| Rigel Pharmaceuticals | ||
| Vanda Pharmaceuticals | ||
| Collegium Pharmaceutical | ||
| Akebia Therapeutics | Not disclosed | Not disclosed |
| Atrion Corporation | Not disclosed | Not disclosed |
| Avid Bioservices, Inc. | Not disclosed | Not disclosed |
| Bioventus | Not disclosed | Not disclosed |
| Heron Therapeutics, Inc. | Not disclosed | Not disclosed |
| Karyopharm Therapeutics, Inc. | Not disclosed | Not disclosed |
| MacroGenics, Inc. | Not disclosed | Not disclosed |
| SurModics, Inc. | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.